Search
for
Sort by
Research 601–630 of 825
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Transgender health and the impact of aging and menopause
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Ovarian surgery for symptom relief in women with polycystic ovary syndrome
- Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function
- Regression of Pathologic Changes Induced by the Long-term Administration of Contraceptive Steroids to Rodents
- Research gaps in medical treatment of transgender/nonbinary people
- Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea
- A Comprehensive Review of Acne Vulgaris
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- Long pulsed Nd: YAG laser with inbuilt cool sapphire tip for long term hair reduction on type- IV and V skin: A prospective analysis of 200 patients
- Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- Recent Advances in the Medical and Surgical Treatment of Priapism
- Androgenetic alopecia – Current status
- Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Autistic-undisciplined thinking in the practice of medical trichology
- Endocrine abnormalities in ring chromosome 11: a case report and review of the literature
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome
- AN OVERVIEW ON POLYCYSTIC OVARIAN SYNDROME
- Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals